Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

This Virus is Spreading Like Wildfire in China—What is HMPV and Why Is It Spreading So Fast?

Daniel Kim Views  

News1
News1

The human metapneumovirus (HMPV), a respiratory infection, is spreading rapidly across China.

Local Chinese media reported a surge in HMPV cases since mid-December. This virus can cause illnesses in the upper and lower respiratory tracts. On the same day, the Indian government confirmed its first case of infection.

HMPV was first identified in 2001. It primarily affects infants and causes acute respiratory symptoms such as pneumonia and fever. The U.S. Centers for Disease Control and Prevention (CDC) states that the virus has an incubation period of three to six days. Symptoms include cough, nasal congestion, fever, and difficulty breathing. These symptoms closely resemble those of influenza, making diagnosis challenging.

Children and adults over 65 are at the highest risk of HMPV progressing to bronchitis or pneumonia. The virus spreads through respiratory droplets from coughs and sneezes, close personal contact, and touching contaminated surfaces before touching one’s face.

Currently, there is no vaccine for HMPV. Prevention methods mirror those used for COVID-19 and other respiratory infections: wearing masks, frequent handwashing, and maintaining good personal hygiene. No specific antiviral treatments exist; doctors manage severe cases by treating symptoms.

Co-infections of HMPV with pneumococcus, influenza, or respiratory syncytial virus (RSV) can lead to more severe outcomes. Experts recommend vaccinating against other respiratory diseases when possible to reduce overall risk.

The CDC reports a steady increase in HMPV cases in the U.S. since November last year. As of December 28, the weekly positive rate for HMPV tests reached 1.94%. While lower than the flu (18.71%) and COVID-19 (7.10%) rates for the same period, HMPV cases are on an upward trend.

Chinese experts emphasize that HMPV is not a new threat but a globally widespread virus. Although it has existed for six decades, its slow spread and often mild symptoms led to its official identification only in 2001.

The rising case numbers in China have led to increased hospitalizations. Analysts attribute this surge to decreased HMPV exposure during the COVID-19 pandemic, which may have weakened community immunity.

India confirmed five HMPV cases on Sunday. Two infants in Bengaluru, Karnataka–a three-month-old girl and an eight-month-old boy–tested positive, along with three other cases in different regions.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[ASIA] Latest Stories

  • Hyundai Ioniq 5 N Time Spec Breaks Tsukuba Circuit Record, Cementing EV Performance Legacy
  • North Korea Sends Young Volunteers to Dangerous Jobs Under the Guise of Voluntary Participation
  • Tension Soars in South Korea’s Presidential Security: Arming Guards with Heavy Weapons After Resignation
  • Democrats Call for Accountability, Push to Investigate Yoon’s ‘Bloodshed’ Tactics
  • Hundreds of Trucks Deliver Scrap Metal Across North Korea for New Year Push
  • 1 Million Chinese Citizens Apply for Asylum During Xi’s Rule, As Repression Increases

You May Also Like

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE 

Must-Reads

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE 

Share it on...